NBRV
Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV
NBRV
Delisted
NBRV was delisted on the 31st of July, 2023.
45 hedge funds and large institutions have $85.9M invested in Nabriva Therapeutics plc Ordinary Shares Ireland in 2018 Q3 according to their latest regulatory filings, with 13 funds opening new positions, 17 increasing their positions, 9 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
71% less call options, than puts
Call options by funds: $32K | Put options by funds: $109K
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
45
Holding in Top 10
–
Calls
$32K
Puts
$109K
Top Buyers
| 1 | +$11.5M | |
| 2 | +$6.87M | |
| 3 | +$4.9M | |
| 4 |
RSCM
Rock Springs Capital Management
Baltimore,
Maryland
|
+$3.13M |
| 5 |
O
OrbiMed
New York
|
+$1.96M |
Top Sellers
| 1 | -$3.27M | |
| 2 | -$2.49M | |
| 3 | -$1.47M | |
| 4 |
Alyeska Investment Group
Chicago,
Illinois
|
-$765K |
| 5 |
VP
venBio Partners
San Francisco,
California
|
-$619K |